Neurology News

The FDA has granted breakthrough device designation to a Spanish health-tech company for its Intelligent Network Modulation System as an adjunctive therapy for treating Parkinson’s disease.

PHILADELPHIA — Individuals who sustained a head injury had a 34% higher risk for suffering ischemic stroke than those who did not have a head injury, according to an expert at the American Neurological Association annual meeting.

An umbrella review published in The BMJ provided a breakdown of the associations between cannabis and health outcomes, highlighting the uncertain potential for clinical use.

PHILADELPHIA — Consideration of multiple factors among patients, families and health care providers drive the process of diagnosing preclinical or prodromal neurologic disease, which should be tailored to the individual, a speaker said.

SAN DIEGO — Psilocybin has emerged as a potential treatment for depression and anxiety, including among patients with chronic rheumatic or autoimmune conditions, according to a speaker at the 2023 Congress of Clinical Rheumatology West.

PHILADELPHIA — Patients with a psychotic-spectrum disorder may be more likely to develop Parkinson’s disease, especially if they have an additional diagnosis of anxiety, according to a poster presentation.

PHILADELPHIA — Individuals who sustained at least one head injury saw an increased risk for developing cognitive issues over a 30-year period compared to those who did not, according to a poster presentation.

SAN DIEGO — Non-pharmacologic approaches to pain management in rheumatology, like exercise and meditation, can be superior to pharmacologic strategies, according to a speaker at the 2023 Congress of Clinical Rheumatology West.

Visual field irregularities, afferent pupillary defects or abnormal optical discs were associated with positive neuroimaging findings among patients presenting to the ED with neuro-ophthalmological complaints, according to a study.

PHILADELPHIA — To effectively address symptoms of dementia with Lewy bodies, the medical community must address obstacles such as accurate diagnosis, lack of treatment options and dearth of clinical trials, according to a presenter.